Literature DB >> 8232089

[Data on the epidemiology of Crohn disease in the city of Cologne].

A Löffler1, M Glados.   

Abstract

In the period between 1.7.1985 and 30.6. 1986 283 patients with Crohn's disease were recorded prospectively in the city of Cologne, which has a total of 922,552 inhabitants. This corresponds to a prevalence of 30.67 per 100,000 inhabitants (women 35.97, men 24.90). During this one-year survey period, 47 new cases of the disease occurred, i.e. the incidence is 5.1 per 100,000 (women 5.8, men 4.3). The highest total incidence is in the age group of 20 to 24 years (17.3) and the highest total prevalence is in the group of 25 to 29 years of age (90.0). There is a substantial sex difference with a female/male ratio of 173:110. Only data of patients residing primarily in Cologne were evaluated. Figures are given on the diagnostic latency, the locations, operations, complications and misdiagnoses of Crohn's disease.

Entities:  

Mesh:

Year:  1993        PMID: 8232089

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

1.  Infliximab paediatric Crohn's disease educational plan: a European, cross-sectional, multicentre evaluation.

Authors:  Alejandro Arana; Sam Allen; Jörg Burkowitz; Valerio Fantoni; Ola Ghatnekar; María Teresa Rico; Nathalie Vanhaverbeke; Charles E Wentworth; Max Brosa; Felix M Arellano
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 2.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

3.  Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh.

Authors:  Abdullah S Al-Ghamdi; Ibrahim A Al-Mofleh; Rashed S Al-Rashed; Saleh M Al-Amri; Abdulrahman M Aljebreen; Arthur C Isnani; Reda El-Badawi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.